Windtree Therapeutics Balance Sheet Health
Financial Health criteria checks 3/6
Windtree Therapeutics has a total shareholder equity of $3.4M and total debt of $15.2M, which brings its debt-to-equity ratio to 449.2%. Its total assets and total liabilities are $32.4M and $29.0M respectively.
Key information
449.2%
Debt to equity ratio
US$15.23m
Debt
| Interest coverage ratio | n/a |
| Cash | US$4.32m |
| Equity | US$3.39m |
| Total liabilities | US$29.02m |
| Total assets | US$32.41m |
Recent financial health updates
Recent updates
Windtree Therapeutics CEO Craig Fraser - Breaking Down Acute Heart Failure (Video)
Dec 06Windtree Therapeutics: Addressing Underserved And Expensive Acute Conditions
Jul 06Shareholders Will Likely Find Windtree Therapeutics, Inc.'s (NASDAQ:WINT) CEO Compensation Acceptable
Jun 09
Should You Take Comfort From Insider Transactions At Windtree Therapeutics, Inc. (NASDAQ:WINT)?
Feb 09Financial Position Analysis
Short Term Liabilities: WINT's short term assets ($5.4M) exceed its short term liabilities ($4.0M).
Long Term Liabilities: WINT's short term assets ($5.4M) do not cover its long term liabilities ($25.0M).
Debt to Equity History and Analysis
Debt Level: WINT's net debt to equity ratio (321.9%) is considered high.
Reducing Debt: WINT's debt to equity ratio has increased from 33.7% to 449.2% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: WINT has sufficient cash runway for 4 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: WINT is forecast to have sufficient cash runway for 3 months based on free cash flow estimates, but has since raised additional capital.